Literature DB >> 20467928

Diabetic cardiomyopathy--to take a long story serious.

Bernd Stratmann1, Thomas Gawlowski, Diethelm Tschoepe.   

Abstract

Being independent of coronary artery disease and hypertension, diabetic cardiomyopathy is a distinct primary disease process, which precedes the development of congestive heart failure. Epidemiologic as well as clinical studies confirmed the close link between diabetes mellitus and heart failure. Altered cardiac structure and function are common diagnoses in patients with type 2 diabetes mellitus. Hyperglycemia leading to the formation of advanced glycation end products and hyperlipidemia resulting in lipotoxicity are of structural and functional impact on cardiac muscle and cardiomyocytes. New and more sensitive methods of diagnosis identify early diastolic dysfunction as a precursor of the development of congestive heart failure. This review focuses on the mechanistic approach to understand the molecular basis of diabetic cardiomyopathy in patients with type 2 diabetes mellitus.

Entities:  

Mesh:

Year:  2010        PMID: 20467928     DOI: 10.1007/s00059-010-3336-0

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  74 in total

Review 1.  Glycoxidation: the menace of diabetes and aging.

Authors:  Helen Vlassara; Marcia Rashelle Palace
Journal:  Mt Sinai J Med       Date:  2003-09

2.  Prognosis following acute myocardial infarction in patients with ECG evidence of left ventricular hypertrophy prior to infarction.

Authors:  M Yotsukura; J Suzuki; T Yamaguchi; K Sasaki; Y Koide; H Mizuno; H Yoshino; K Ishikawa
Journal:  J Electrocardiol       Date:  1998-04       Impact factor: 1.438

3.  Measurement of methylglyoxal in rat tissues by electrospray ionization mass spectrometry and liquid chromatography.

Authors:  E W Randell; S Vasdev; V Gill
Journal:  J Pharmacol Toxicol Methods       Date:  2005 Mar-Apr       Impact factor: 1.950

4.  Glycemic control and heart failure among adult patients with diabetes.

Authors:  C Iribarren; A J Karter; A S Go; A Ferrara; J Y Liu; S Sidney; J V Selby
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

5.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

Authors:  S Neubauer; M Horn; M Cramer; K Harre; J B Newell; W Peters; T Pabst; G Ertl; D Hahn; J S Ingwall; K Kochsiek
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

6.  Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients.

Authors:  Lucilla D Monti; Claudio Landoni; Emanuela Setola; Elena Galluccio; Pietro Lucotti; Emilia P Sandoli; Anna Origgi; Giovanni Lucignani; PierMarco Piatti; Ferruccio Fazio
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-06       Impact factor: 4.733

7.  Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.

Authors:  John K Boyer; Srihari Thanigaraj; Kenneth B Schechtman; Julio E Pérez
Journal:  Am J Cardiol       Date:  2004-04-01       Impact factor: 2.778

Review 8.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

9.  Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis.

Authors:  Laura L Atkinson; Melanie A Fischer; Gary D Lopaschuk
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

10.  Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus.

Authors:  M Kalousová; J Skrha; T Zima
Journal:  Physiol Res       Date:  2002       Impact factor: 1.881

View more
  7 in total

1.  [Cardiac rehabilitation--more than just for the garden plot?].

Authors:  B Maisch
Journal:  Herz       Date:  2012-02       Impact factor: 1.443

Review 2.  Sirtuin 3, Endothelial Metabolic Reprogramming, and Heart Failure With Preserved Ejection Fraction.

Authors:  Heng Zeng; Jian-Xiong Chen
Journal:  J Cardiovasc Pharmacol       Date:  2019-10       Impact factor: 3.105

3.  Diabetic cardiomyopathy--fact or fiction?

Authors:  B Maisch; P Alter; S Pankuweit
Journal:  Herz       Date:  2011-03       Impact factor: 1.443

4.  Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3.

Authors:  Heng Zeng; Xiaochen He; Xuwei Hou; Lanfang Li; Jian-Xiong Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-20       Impact factor: 4.733

5.  Sirtuin 3 Alleviates Diabetic Cardiomyopathy by Regulating TIGAR and Cardiomyocyte Metabolism.

Authors:  Lanfang Li; Heng Zeng; Xiaochen He; Jian-Xiong Chen
Journal:  J Am Heart Assoc       Date:  2021-02-15       Impact factor: 5.501

6.  Intracellular Accumulation of Methylglyoxal by Glyoxalase 1 Knock Down Alters Collagen Homoeostasis in L6 Myoblasts.

Authors:  Bernd Stratmann; Bernhard Goldstein; Paul J Thornalley; Naila Rabbani; Diethelm Tschoepe
Journal:  Int J Mol Sci       Date:  2017-02-23       Impact factor: 5.923

7.  Impact of GLO1 knock down on GLUT4 trafficking and glucose uptake in L6 myoblasts.

Authors:  Britta Engelbrecht; Bernd Stratmann; Cornelius Hess; Diethelm Tschoepe; Thomas Gawlowski
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.